Involvement of follistatin-like 3 in preeclampsia

Biochem Biophys Res Commun. 2018 Nov 30;506(3):692-697. doi: 10.1016/j.bbrc.2018.10.139. Epub 2018 Oct 27.

Abstract

Introduction: Preeclampsia is a main cause of maternal and perinatal mortality and morbidity. The expression of follistatin-like 3 (FSTL3) is enhanced in maternal serum and placenta of preeclamptic women. However, whether FSTL3 is involved in the pathophysiologic of preeclampsia has not been clarified yet.

Method: Trophoblast cell lines Swan71 and JAR cells were cultured and siRNA was used to silence FSTL3. The expression of FSTL3 was determined by Western blotting. The matrigel-coated transwell and wound healing assays were used to assess invasion and migration, cell proliferation and apoptosis were detected by CCK-8 and flow cytometric analysis, respectively. Oil red O staining was used to detect the lipid storage in trophoblast.

Results: Hypoxia culture significantly enhanced the expression of FSTL3 by trophoblast. Down-regulation of FSTL3 significantly suppressed the proliferation, migration, invasion and lipid storage but increased apoptosis of trophoblast.

Discussion: Aberrant expression of FSTL3 in preeclampsia led to the dysfunction of trophoblast, indicating its involvement in the pathogenesis of preeclampsia.

Keywords: Follistatin-like 3; Preeclampsia; Trophoblast.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Cell Line
  • Cell Movement
  • Cell Proliferation
  • Female
  • Follistatin-Related Proteins / metabolism*
  • Gene Knockdown Techniques
  • Humans
  • Lipid Metabolism
  • Pre-Eclampsia / metabolism*
  • Pregnancy
  • RNA, Small Interfering / metabolism
  • Trophoblasts / metabolism

Substances

  • Follistatin-Related Proteins
  • Fstl3 protein, human
  • RNA, Small Interfering